Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffering from blood cancers. Nonetheless, significant morbidity and mortality are still prevalent. One major complication is graft versus host disease (GvHD) which occurs in 30-70% of patients. In this dis...
Egile nagusia: | Leuschner, U |
---|---|
Beste egile batzuk: | Roberts, D |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
2021
|
Antzeko izenburuak
-
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
nork: Mauro Di Ianni, et al.
Argitaratua: (2024-01-01) -
The Role of Bacteria and Pattern Recognition Receptors in GvHD
nork: E. Holler, et al.
Argitaratua: (2010-01-01) -
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
nork: Haroon Shaikh, et al.
Argitaratua: (2022-11-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
nork: Martin eSzyska, et al.
Argitaratua: (2016-03-01) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
nork: Kudakwashe Mhandire, et al.
Argitaratua: (2021-10-01)